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Leptospirosis is an infectious disease caused by the spirochete bacteria Leptospira spp. and is commonly found throughout the
world. Diagnosis of leptospirosis performed by culture andmicroscopic agglutination tests is laborious and time-consuming.
Therefore, we aimed to develop a novel immunochromatography (ICG)-based method for detecting Leptospira antigen in the
urine of patients and animals. We used the 1H6monoclonal antibody (MAb), which is specific to the lipopolysaccharide (LPS)
that is common among Leptospira spp. TheMAb was coupled to 40-nm-diameter colloidal gold, and the amounts of labeled anti-
body and immobilized antibody were 23g and 2g per test, respectively. Several strains of Leptospira and other bacterial spe-
cies were used to evaluate the sensitivities and specificities of the assays we developed. The detection limit of the assays was 106
cells/ml when disrupted whole bacterial cells were used. The assays were Leptospira specific since they did not cross-react with
non-Leptospira bacteria used in the study. Application of diagnostic assays was done on the urine samples of 46 Leptospira-in-
fected hamsters, 44 patients with suspected leptospirosis, and 14 healthy individuals. Pretreatment of the urine samples by boil-
ing and centrifugation (for ultrafiltration and concentration) eliminated nonspecific reactions that occurred in the assay. The
sensitivity and specificity of the ICG-based lateral flow assay (LFA) were 89% and 87%, respectively, which were higher than
those of the dipstick assay, which were 80% and 74%, respectively. In summary, this ICG-based LFA can be used as an alternative
diagnostic assay for leptospirosis. Further development is still necessary to improve the assay.
The genus Leptospira, belonging to the order Spirochaetales andfamily Leptospiraceae, comprises spiral-shaped bacteria that
are 0.1 m in diameter and 6 to 20 m in length and that have
hooked ends (1). Leptospira organisms are Gram negative and
obligately aerobic (2). Infection in humans or animals might hap-
pen by penetration of Leptospira, excreted by infected host ani-
mals into the environment, through a wound or mucous mem-
brane. Signs and symptoms of leptospirosis in humans range from
mild flu-like symptoms to jaundice (hepatic dysfunction), oligu-
ria or anuria (renal failure), and hemoptysis (lung hemorrhage),
which can lead to death (3).
Several assays can be applied for leptospirosis diagnosis. The
World Health Organization (WHO) has specified standard re-
quirements for leptospirosis patients, such as sufficient growth of
leptospires from a normally sterile organ, a clear amplified DNA
band in PCR, and a 4-fold increase of titers between acute- and
convalescent-phase sera in a microscopic agglutination test
(MAT) (4). Unfortunately, MAT is laborious and time-consum-
ing, and PCR is expensive due to the need for sophisticated equip-
ment. Because leptospirosis is commonly found in developing or
underdeveloped countries, there is a need for rapid, reliable, and
inexpensive diagnostic kits. Diagnostic assays were developed sev-
eral years ago, such as flow-through (5), IgM dipstick (6), immu-
nofluorescence (7), and latex agglutination (8), which detected
the presence of antibodies in human serum samples. Nevertheless,
the sensitivity and specificity of these methods were low when
performed during the early stage of infection with Leptospira be-
cause the appropriate immune response might not yet have been
elicited by the time of specimen collection. For example, the dip-
stick assay (6), which can detect the presence of IgM and is often
used in the initial screening of leptospirosis, has low sensitivity
when applied to patient serum samples (9). An antigen detection
assay might offer an effective solution to this difficulty, because
antigen can be detected earlier after infection (10). Assays for the
detection of Leptospira antigen and DNA are still being developed
(11, 12). An immunochromatography (ICG)-based assay might
be a solution because it is inexpensive, rapid, and easy to perform.
An ICG-based assay for the detection of bacterial antigen in clin-
ical samples has been performed on several bacterial species, such
as Legionella pneumophila (13), Streptococcus pneumoniae (14),
and Neisseria meningitidis (15). In our study, we tried to develop
an ICG-based assay for antigen detection in Leptospira, which
could be applied in areas where leptospirosis infection is endemic
and that is applicable for detecting antigen in urine samples.
MATERIALS AND METHODS
Bacteria and culture. The bacterial species used in this study are listed in
Table 1. These bacteria were cultured inmodified Korthof’s medium (16)
for Leptospira spp., brain heart infusion (BHI) broth (Difco) for Strepto-
coccus spp. and Enterococcus spp., selective buffered charcoal yeast extract
 (BCYE) for Legionella spp., and Luria-Bertani (LB) medium for Esch-
erichia coli and Pseudomonas spp. These organisms were then used to
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examine the specificity and sensitivity of the assays developed or as infec-
tion agents in hamsters (Leptospira spp. only).
Monoclonal antibody production. Six-week-old BALB/c mice were
primed intraperitoneally with 0.2 ml of a mixture of equal volumes of 0.1
mg of the heat-killed Leptospira interrogans serovar Icterohaemorrhagiae
strain RGA (1.0  108 cells/ml in phosphate-buffered saline [PBS]) and
Freund’s complete adjuvant. The mice were immunized two more times
at 1-week intervals using the same immunogen and the same route, but
instead with Freund’s incomplete adjuvant. Three days after the last
booster, the mice were sacrificed. Hybridomas were generated following
the fusion of splenocytes with P3-X63-Ag8.653 myeloma cells, and se-
lected cultures were grown following standard procedure (17). Hybrid-
omas were screened for the secretion of the desired antibodies with an
enzyme-linked immunosorbent assay (ELISA) and Western blotting us-
ing homologous sonicated antigen. Positive hybridoma cells were cloned
using limiting dilution to obtain antibodies from a single cell. Hybridoma
culture supernatants or ascitic fluid, both of which were harvested after in
vivo culture of hybridoma, were used as the 1H6 monoclonal antibody
(MAb) source. Purification of protein fromhybridomawas carried out by
ammonium sulfate precipitation, followed by affinity chromatography
(18) through a HiTrap Protein G HP column (GE Healthcare) in the
presence of 1.5 M glycine (pH 9.0). Purified antibody was analyzed by
SDS-PAGE, and quantitative measurement was determined by UV ab-
sorption (18). The immunoglobulin subclass was determined using a
mouse monoclonal antibody isotyping kit (GEHealthcare), following the
manufacturer’s instructions.
Antigen specificity of MAbs. Specificity of the generated MAb, 1H6,
was tested by immunoblotting against bacterial antigens, including the
lipopolysaccharide (LPS) of several bacterial species. The LPS was ex-
tracted using chloroform-methanol extraction (19), followed by silica col-
umn chromatography (18) using Iatrobeads 6RS-8060 (Iatron Laborato-
ries, Inc.). LPS was analyzed by SDS-PAGE with Pro-Q Emerald staining
(Invitrogen). Immunoblotting of LPSwas performed using the 1H6MAb.
Animal and human urine. Four-week-old golden Syrian hamsters
(Japan SLC, Inc., Hamamatsu, Japan) were infected with L. interrogans
serovars Manilae, Losbanos, Pyrogenes, and Canicola. Seven to 14 days
after infection, urine specimens were collected by aseptic aspiration from
the urinary bladders of the dead or sacrificed hamsters. A part of the urine
sample was then cultured in modified Korthof’s medium and observed
until 1 month of incubation at 30°C. Urine was also used to find the
optimum conditions for sample treatment. Forty-four urine samples
from patients with suspected leptospirosis and 14 samples from healthy
persons were obtained from the College of Public Health, University of
Philippines—Manila and Kyushu University, respectively. These urine
samples were tested by dipstick assay, immunochromatographic assay,
and PCR.
Pretreatment of urine. Optimization of urine treatment was per-
formed using Leptospira-infected- and noninfected-hamster urine sam-
ples treated using several methods: (i) boiling for 5 min (20), (ii) centrif-
ugation at 20,000  g for 15 min (21) followed by resuspension of
precipitate with phosphate buffer (pH 7.2), (iii) ultrafiltration and con-
centration (22), and (iv) boiling for 5 min, centrifugation at 1,000 g for
15 min, and centrifugation (for ultrafiltration and concentration) of su-
pernatant. Ultrafiltration and concentration of urine in methods (iii) and
(iv) were performed two times by filtering the supernatant with an Ami-
con Ultra 30K (Millipore) filter and collecting the filtrate. It was then
filtered and concentrated using an Amicon Ultra 10K device (Millipore).
The concentrate was resuspended using 10 mM phosphate buffer (pH
7.2). Centrifugation speed (14,000 g) and time (i.e., 10 min and 15min
for Amicon 30K and 10K, respectively) were selected according to the
manufacturer’s instructions. As a result, urine samples were concentrated
10 times. Those samples were then tested using the dipstick assay to de-
termine the best conditions for urine treatment for analyzing urine sam-
ples from patients and hamsters.
Microscopic agglutination test. MAT of serum samples from the
same patients with urine samples was performed using the standard
method (16, 23). The endpoint titer was the serum dilution that gave
50% agglutination at a titer of1:400.
Gold conjugation of MAbs. Gold colloid with a 40-nm diameter (BB
International, United Kingdom)was adjusted to pH 9 using 0.1MK2CO3
(24) and then was mixed with 23 g/ml purified MAb. After 1 h of incu-
bation at room temperature with slow mixing, 0.1% of skim milk was
added to block unconjugated sites and was incubated for 10 min. Gold-
conjugated antibodies were separated by centrifugation at 6,000 g for 1
hour, washed two times with 2 mM borate buffer (pH 7.2), and kept in
10% initial volume of storage buffer (2 mM borate buffer [pH 7.2], 0.1%
skim milk) (25).
Preparation of dipstick and immunochromatography-based lateral
flow assays (LFA). (i)Membrane.NitrocellulosemembraneHF240 (Mil-
lipore) was cut into 0.5-cm widths. Two micrograms of 1H6MAb in 2 l
was dropped on the test (T) area, while 2 g of goat anti-mouse IgG
antibody (Rockland) in 2 l was dropped on the internal control (IC)
area. Themembrane was dried in a desiccator for 1 to 2 h at 37°C. In order
to block the unconjugated areas, the membrane was dipped in 10 mM
phosphate buffer (pH 7.2) containing 1% skim milk for 15 min and was
washed two times in the same buffer to wash off any excessive blocking
reagent. The membrane was then dried overnight at room temperature.
(ii) Conjugate pad. Glass fiber conjugate pads (Millipore), 1 by 0.5
cm, were dipped in gold-conjugated antibodies dissolved in 2 mM borate
buffer (pH 7.2) plus 5% sucrose. The pad was then dried at 37°C for 2 h
(26).
(iii) Sample pad. Sample pads were treated according to Shim et al.
(27), with some modifications. Cellulose fiber sample pads (Millipore),
1.5 by 0.5 cm, were dipped into the sample pad buffer (50 mM borate
buffer [pH 7.2], 5% sucrose, 0.5% Tween 20, 5% dextran, and 0.1% skim
milk) and then dried at 50°C.
TABLE 1 List of organisms used in this study
Bacterial species Strain Serovar or serogroup
Leptospira interrogans Akiyami A Autumnalis
Hond Utrecht IV Canicola
K64 Manilae
K5 Grippotyphosa
Ictero no. 1 Icterohaemorrhagiae
K37 Losbanos
Hebdomadis Hebdomadis
Leptospira borgpetersenii Poi Poi
Perepelitsin Tarassovi
K6 Javanica
Leptospira biflexa Patoc 1 Patoc
Escherichia coli K-12 MG 1655
C16
C17
Legionella pneumophila Philadelphia-1
(ATCC 33152)
Enterococcus faecalis Portland (ATCC
29212)
Pseudomonas aeruginosa PAGU 221
Streptococcus pneumoniae ATCC 1127
Serratia marcescens J1
J5
Borrelia burgdorferi B31
Borrelia afzelii P/Gau
Widiyanti et al.
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(iv) Dipstick assay. Forty microliters of pretreated urine sample was
put into a 96-well microtiter plate. Twelve microliters of gold-conjugated
antibodies was mixed with the sample. The mixture was incubated for 15
min at room temperature. The dipsticks were dipped into the mixture,
and the results were observed for a maximum of 15 min. Positive test
results were indicated by two red spots (in the internal control [IC] area
and test area), while negative test results were shown by only one red spot
(in the internal control area). The test was invalid if no red spot appeared
in the IC area.
(v) ICG-based LFA.One hundred microliters of sample was dropped
onto the sample pad. The results were observed for amaximumof 15min.
The interpretation of results was the same as in the dipstick assay.
Sensitivity and specificity of the tests. Leptospira strains were culti-
vated in modified Korthof’s medium for several days and were counted
using a Thoma counting chamber. The leptospiral culturewas centrifuged
at 10,000 g for 20min. Cultures of Streptococcus spp., Enterococcus spp.,
Legionella spp., E. coli, and Pseudomonas spp. were centrifuged at 9,000
g for 20 min. The pellets were washed and resuspended in 10 mM phos-
phate buffer (pH 7.2). The assay detection limit was tested using dilutions
of 107 to 101 cells of L. interrogans serovar Manilae strain K64, a local
isolate from the Philippines (23). The cells were sonicated in the same
buffer and were used for the sensitivity test. The specificity of the assays
was tested using the bacterial species listed in Table 1.
PCR. Urine samples were centrifuged at 13,000  g for 10 min.
Genomic DNA was purified from the pellet using the Illustra bacterial
genomic prep mini spin kit (GE Healthcare, United Kingdom) according
to the manufacturer’s instructions. Two kinds of PCR assays were per-
formed that targeted the flaB gene (793 bp), which is specific for patho-
genic Leptospira spp. (28), and the rrl gene (482 bp), which is specific for
Leptospira genus (29). The primers used in this experiment were specific
for the flaB gene (L-flaB-F1 [5=-TCTCACCGTTCTCTAAAGTTCAAC-
3=] and L-flaB-R1 [5=-CTGAATTCGGTTTCATATTTGCC-3=]) (27) and
for the rrl gene (rrlF [5=-GACCCGAAGCCTGTCGAG-3=] and rrlR [5=-
GCCATGCTTAGTCCCGATTAC-3=]) (29) of Leptospira spp. flaB was
amplified under the following conditions: 40 cycles of denaturing at 94°C
for 20 s, annealing at 50°C for 30 s, extension at 72°C for 60 s, and final
extension at 72°C for 5 min. The PCR condition for rrl was determined
according to Léon et al. (29). PCR products were electrophoresed using
0.7% agarose gel and visualized using ethidium bromide stain.
Statistical analysis. The minimum sample size required for the pres-
ent study was estimated allowing for an error of 10% and for assumed
sensitivities and specificities of 85% each. To test the differences between
ICG-based LFA and dipstick assay, when compared with the gold stan-
dard, data were analyzed using the Wilcoxon test using SPSS 17.0.
Human and animal ethics. The Ethics Committee on Animal Experi-
ment at the Faculty of Medical Sciences, Kyushu University, reviewed and
approved all the animal experiments in this study. These experiments were
donebasedon the conditions stated in theGuideline forAnimalExperiments
of Kyushu University (law 8 no. 105) and notification no. 6 of the Govern-
ment of Japan.Human sampleswere obtained after verbal andwritten expla-
nations of the study and procedures and after the consent of the subjects or
their guardian(s) (for patients with suspected leptospirosis) was obtained.
The Ethics Committee of Kyushu University and University of the Philip-
pines—Manila approved the conduct of this study on samples fromhumans.
RESULTS
Characterization of monoclonal antibody. SDS-PAGE analysis
of purified monoclonal antibodies was carried out. Under nonre-
ducing conditions (i.e., without the addition of dithiothreitol
[DTT]), a band of antibodywas seen around 170 kDa,while under
reducing conditions, a heavy chain was noted around 60 kDa and
a light chain was seen at 25 kDa (30). Based on these results, the
antileptospiral LPS antibody was successfully purified by the
method used here. LPS was extracted, purified, and electropho-
resed as shown in Fig. 1 (upper panel). Immunoblotting with 1H6
MAb to the purified LPS showed that the antibody was specific to
the LPS of L. interrogans (Fig. 1, lower panel).We determined that
the purified MAb was of class IgG3 based on typing result.
Optimization of conjugation of gold with monoclonal anti-
body. Preliminary experiments were performed to find the opti-
mal combination of antibodies (Abs) using both polyclonal and
monoclonal antibodies. When we used polyclonal antibodies pu-
rified from guinea pigs infected with five strains of Leptospira, we
found many false-positive results. Therefore, we tried to use one
monoclonal antibody as a capture Ab and immobilized Ab, which
showed better results than other combinations of antibodies (data
not shown).
Preliminary experiments were also carried out to determine
the optimum conditions for conjugating antibodies with gold col-
loid. Prior to the conjugation of gold colloid and monoclonal
antibody, titration was performed to determine the least amount
of antibody that could stabilize gold colloid. Using the method
described in the study by Beesley (24), with some modifications,
the minimal concentration of antibody was determined (data not
shown) and 23g/ml (four times theminimumconcentration) of
antibodywas used for conjugationwith gold colloid. After prelim-
inary experiments using different concentrations, the dose of im-
mobilized antibody was determined to be 2 g (data not shown).
Sensitivity and specificity of the dipstick assay. A positive re-
sult in the dipstick assay was seen with 107 to 106 cells.Meanwhile,
with 105 cells, the antigen could no longer be detected. Therefore,
the detection limit of the dipstick assay was determined to be 106
cells/ml when disrupted cells of Leptospira were used.
The specificity of the dipstick assay was tested against several
bacterial species, which are listed in Table 1. Results showed that
the assay has a high specificity for all strains of Leptospira used in
this study, whether pathogenic or not (L. interrogans serovars Au-
tumnalis, Canicola, Manilae, Grippotyphosa, and Icterohaemor-
rhagiae Leptospira borgpetersenii serovars Poi, Tarassovi, and Ja-
vanica, and Leptospira biflexa serovar Patoc). However, the assay
was negative when other bacterial species were used, such as those
whose antigens are known to be excreted in urine (L. pneumophila
and S. pneumoniae), and in uropathogenic bacteria (E. coli, En-
terococcus faecalis, and P. aeruginosa). The results showed that this
assay could discriminate Leptospira from other bacteria, but it
FIG 1 Detection of MAb (1H6)-reactive antigen in Leptospira and other bac-
teria. SDS-PAGE of bacterial LPS with Pro-Q Emerald staining (upper panel)
and immunoblotting with MAb-1H6 (lower panel). Lane 1, Legionella pneu-
mophila; lanes 2 and 3, uropathogenic E. coli C16 and C17; lanes 4 and 5,
Serratia marcescens J1 and J5; lane 6, Streptococcus pyogenes; lane 7, Borrelia
burgdorferi B31; lane 8, Borrelia afzelii P/Gau; lane 9, L. interrogans serovar
Hebdomadis; and lane 10, bovine serum albumin (BSA).
Detection of Leptospiral Antigen in Urine
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could not discriminate pathogenic from nonpathogenic Lepto-
spira.
Determination of the best conditions for sample treatment.
Treatment of urine samples was carried out to determine the con-
ditions that might increase the sensitivity and specificity of the
assays. Treatment was necessary because of nonspecific bindings
based on the immunoblotting results of urine samples from pa-
tients with suspected leptospirosis (data not shown).
The results of the dipstick assay showed that leptospiral antigen
could be detected in the urine of Leptospira-infected hamsters af-
ter using all sample treatments. However, when we used unin-
fected-hamster urine samples that were not treated, were only
boiled, or were only centrifuged, the dipstick assay was positive. In
a study by Doskeland and Berdal (31), boiling urine eliminated
nonspecific reactions by substances in it. In our study, however,
boiling alone was not enough to eliminate these reactions, prob-
ably due to a heat-stable substance that bound to gold-conjugated
antibody. Centrifugation at 20,000  g was used to increase the
sensitivity of the assay, but it did not eliminate the nonspecific
substances that interfered with the result. A combination of boil-
ing and centrifugal filtration, however, eliminated the nonspecific
reactions in uninfected-hamster urine samples. Based on the re-
sults of our study and those of Cinco et al. (32), the lipopolysac-
charide of Leptospira has a size between 10 and 30 kDa; therefore,
we used two kinds of ultrafilters to obtain the antigen of this size.
Using this method, we successfully eliminated the nonspecific
substance in uninfected-hamster urine. Thesemethods, therefore,
might be used to pretreat the urine samples of infected hamsters
and patients with suspected leptospirosis prior to analysis using
the two diagnostic methods.
Dipstick assay for Leptospira-infected hamster urine. The
minimum sample size calculated for this study was 13. Forty-six
urine samples of Leptospira-infected hamsters were collected and
stored at 20°C prior to testing. The optimum conditions of
urine treatmentmentioned abovewere used prior to analyzing the
infected-hamster urine using the dipstick assay. Figure 2 shows
the representative results of the dipstick assay.
Results of the dipstick assay showed that 28 of 46 samples of
hamster urine (60.9%) were positive, while 29 of 46 samples
(63.1%) were positive in culture. The sensitivity and specificity of
the dipstick assay were calculated by comparing the results with
the gold standard (i.e., culture) (Table 2) and were found to be
76% and 65%, respectively. Some discrepancies between the dip-
stick assay and culture results were observed.
Dipstick and ICG-based LFA for urine of humans with sus-
pected leptospirosis.Urine samples from patients with suspected
leptospirosis were collected, stored at20°C prior to testing, and
then tested using the dipstick assay, ICG-based LFA, and PCR.
Serum samples of patients were tested usingMAT. For the human
urine samples, we performed the dipstick assay, ICG-based LFA,
and PCR, because the amounts of the samples were enough to
perform all 3 methods. The representative results of ICG-based
LFA are shown in Fig. 3. For determining the specificity of the
assays, we also tested urine samples fromhealthy persons using the
dipstick assay and ICG-based LFA. PCR was used to confirm
the results of the 2 assays.
flaB PCR was more sensitive in detecting Leptospira in urine
than was rrl.We found discrepancies between the results of MAT
and PCR. Since these 2 methods were used as gold standards, to
calculate the sensitivity and specificity of the dipstick assay and
ICG-based LFA, the gold standard was considered positive when
either of these two methods was positive.
The assays developed in this study could detect the antigen
from the first day after the onset of illness, as shown in Table 3.
Compared to the gold standard (PCR and/or MAT), different re-
sults of both assays were found mostly by the fifth day after onset
in 19 samples and became relatively consistent from the sixth day
on. By the fifth day after onset, we found 6 false-negative and 3
false-positive results for the dipstick assay and 3 false-negative and
2 false-positive results for the ICG-based LFA. After the sixth day,
we found only 1 false-positive result for ICG-based LFA and 1
false-negative result for both assays with an unknown time of dis-
ease onset. From 44 samples from patients with suspected lepto-
spirosis, 4 samples were negative for all assays; therefore, we de-
duced that these patients were not infected by Leptospira. The
results from the urine samples of patients with suspected leptospi-
rosis and healthy persons showed that 35 of 58 samples (60.3%)
were positive for MAT or PCR. Thirty-four of the 58 samples
(58.7%) were positive in the dipstick assay and ICG-based LFA, as
shown in Tables 4 and 5. The sensitivity and specificity of the
dipstick assay were 80% and 74%, respectively. The results of the
FIG 2 Dipstick assay using hamster urine. (A) Negative result; (B) positive
result.
TABLE 2 Comparison of dipstick assay results with culture method
using infected-hamster urinea
Dipstick
Culture method
Positive Negative Total
Positive 22 6 28
Negative 7 11 18
Total 29 17 46
a Sensitivity, 0.76 (76%) (95% CI, 0.63–0.89); specificity, 0.65 (65%) (95% CI, 0.51–
0.79). Values are number of samples.
FIG 3 ICG-based LFA using human urine. (A) Negative result; (B) positive
result.
Widiyanti et al.
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ICG-based LFA and gold standard are shown in Table 5, and the
sensitivity and specificity were 89% and 87%, respectively. The
sensitivity and specificity of the ICG-based LFA were higher than
those of the dipstick assay. The Wilcoxon analysis also showed
that the ICG-based LFA was not significantly different from the
gold standard (P  0.3557,   0.05). The efficiencies of the
dipstick assay and ICG-based LFA were 78% and 88%, respec-
tively. These results showed that the ICG-based LFA is better than
the dipstick assay due to its higher sensitivity, specificity, and effi-
ciency.
TABLE 4 Comparison of dipstick assay results with PCR (human urine)
and/or MAT (human serum)a
Dipstick
PCR and/or MAT
Positive Negative Total
Positive 28 6 34
Negative 7 17 24
Total 35 23 58
a Sensitivity, 0.8 (80%) (95% CI, 0.7–0.9); specificity, 0.74 (74%) (95% CI, 0.63–0.85).
Values are number of samples.
TABLE 3 Results of MAT, PCR, dipstick, and ICG-based LFA on urine samples from suspected-leptospirosis patients
Patient
no.
Day of urine
collection
after onset
of illness
Assay result
MAT serovars (titers)Dipstick
ICG-based
LFA PCR MAT
1 1     Copenhageni (1:400)
2 2    
3 2     Patoc (1:3,200)
4 2     Poi (1:400)
5 3    
6 3    
7 3    
8 3    
9 3     Patoc (1:1,600), Poi (1:400)
10 3     Patoc (1:400)
11 4     Manilae (1:800), Patoc (1:800)
12 4     Poi (1:400)
13 4     Copenhageni (1:800), Patoc (1:400)
14 4     Patoc (1:1,600)
15 4     Patoc (1:400)
16 4    
17 5    
18 5     Pyrogenes (1:400)
19 5    
20 6     Patoc (1:400)
21 6     Canicola (1:800)
22 6    
23 7    
24 7     Patoc (1:6,400)
25 8    
26 8     Patoc (1:6,400)
27 8     Patoc (1:800)
28 8     Patoc (1:1,600), Copenhageni (1:800), Semaranga (1:800)
29 9     Poi (1:800), Patoc (1:400)
30 10    
31 12     Losbanos (1:400)
32 13     Copenhageni (1:400), Losbanos (1:400)
33 14    
34 15     Patoc (1:3,200)
35 18     Ratnapura (1:1,600), Poi (1:800), Patoc (1:800), Semaranga (1:400)
36 21    
37 22     Patoc (1:3,200), Pyrogenes (1:800)
38 52     Ratnapura (1:1,600), Copenhageni (1:400), Patoc (1:400), Semaranga (1:400)
39 68     Patoc (1:6,400), Canicola (1:800), Ratnapura (1:800), Semaranga (1:800)
40 Unknown     Patoc (1:800)
41 Unknown     Patoc (1:800), Losbanos (1:400)
42 Unknown     Semaranga (1:1,600), Patoc (1:400)
43 Unknown    
44 Unknown    
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DISCUSSION
Leptospirosis is an infectious disease prevailing around the world.
The diagnosis of leptospirosis is mainly determined byMAT, cul-
ture, and PCR methods (16). However, the limitations of these
assays (i.e., they are laborious, time-consuming, and expensive)
brought out the need for another simple, fast, and inexpensive
diagnostic method. In this study, we tried to develop a rapid diag-
nostic assay (i.e., dipstick and ICG-based LFA) for leptospirosis
which might fulfill these requirements and be applicable in all
countries. Nowadays, the ICG assay for leptospirosis, which is
used as one of the diagnostic methods, is mainly used for the
detection of antibodies (9, 33, 34). However, these assays are dif-
ficult to use for early diagnosis because of their low sensitivities
and the fact that the immune response might not have developed
enough to be detected during the early stages of infection. The
antigen of Leptospiramight be a good target for detection, partic-
ularly during the early phase of infection, because it is excreted in
the urine from day 6 postinfection onward (10, 35). Therefore, we
tried to develop ICG-based methods that aimed to detect the an-
tigen of Leptospira using anti-Leptospira antibodies.
The monoclonal antibody 1H6, which was used in this study,
has been characterized as against the lipopolysaccharide of Lepto-
spira. This antibody was tested for purified LPS of several bacterial
species prior to the development of the diagnostic kit. The mono-
clonal antibody was reactive to the 12-kDa LPS of Leptospira, as
seen in Fig. 1. Leptospiral LPS is known to have high antigenicity,
and therefore, anti-LPS antibodies are found in human and ani-
mal sera (36).
Preliminary experiments using combinations of polyclonal
and monoclonal antibodies showed false-positive results due to
possible nonspecific reactions. Polyclonal antibodies produced by
the immunization of whole bacteria resulted in low specificity
(37). By using only one kind ofmonoclonal antibody, we achieved
better results than with a combination of polyclonal and mono-
clonal antibodies. We hypothesized that there are multiple
epitopes in one molecule of LPS and that the capture antibody
bound to one of the epitopes while the immobilized antibody
bound to unoccupied epitopes. Usage of a single antibody for
capture and immobilized antigens was also reported in ICG-based
methods, which were successful in detecting Campylobacter anti-
gens (38) and botulinum neurotoxin (39). This single antibody
was adapted for our dipstick assay and ICG-based LFA, which
were tested for sensitivity and specificity against Leptospira spp.
and other bacterial species. For sensitivity, we have tested different
concentrations of Leptospira culture, and the detection limit was
106 cells/ml. This result was almost the same as the detection limit
of that achieved with the immunochromatographic assay for
other bacterial species (25, 37). For a specificity assay, we tested
this single antibody system against several strains of Leptospira
and bacteria that are commonly found in urine or are known to be
the causative agents of urinary infection. Results showed that all
Leptospira spp. could be detected, but the non-Leptospira bacteria
used in this study could not, which means this assay can discrim-
inate between Leptospira antigen and other bacterial antigens.
Themethodwas applied to infected- and noninfected-hamster
urine samples and was compared with cultures. Direct applica-
tions of the hamster urine always gave false-positive results for
noninfected-hamster urine. This might be caused by nonspecific
reactions with unknown substances in the urine. Therefore, pre-
treatment of the urinewas necessary to eliminate these substances.
Boiling urine for 3 min might cause the liberation of LPS antigen
from the naturally formed antigen-antibody complex and in-
crease a specific antigen-antibody reaction (31). However, in this
study, pretreatment of urine by boiling only was not enough to
eliminate nonspecific reactions. A combination of boiling and
concentrating (through ultrafiltration) urine might eliminate
nonspecific reactions in uninfected-hamster urine in our study.
Concentration and filtration of urine were believed to increase the
sensitivity and specificity of diagnostic assays (20). This result was
consistent when using human urine (unpublished data). How-
ever, further study is necessary in order to create simpler and
more-cost-effective methods of pretreating urine samples.
A dipstick assay was applied to the urine samples of 46 infected
hamsters. The culture method was used as a comparison method
and a gold standard for the calculation of sensitivity and specific-
ity. The culture method is known to be one of the reference diag-
nostic tests for leptospirosis (4). The sensitivity and specificity of
the dipstick assay were 76% and 65%, respectively. These results
were quite low when comparing the dipstick assay with the detec-
tion of Leptospira antibody in serum (40, 41), which showed
90% sensitivity and specificity. This might be caused by the rel-
atively small amount of Leptospira antigens in the sample. We
have estimated that the detection limit for the dipstick assay is 106
cells of Leptospira. The concentration of Leptospira that is usually
found in urine from dogs ranges from 101 to 106 cells/ml (42).
Monahan et al. (10) reported that rats could excrete high concen-
trations of Leptospira (107 cells/ml) after 3 weeks of infection.
Because the concentration of Leptospira varies among animals,
this kit might not be applicable for samples with leptospiral con-
centrations below the detection limit. For infected-hamster urine,
we tested using the dipstick assay only, due to the limited volume
of samples.
Urine samples from 44 patients with suspected leptospirosis
and 14 healthy humans were tested using the dipstick assay and
ICG-based LFA. PCR and MAT were also performed and were
used as gold standards because we found several discrepancies
betweenPCRandMAT results, as shown inTable 3. Some samples
were positive by PCR but negative byMAT. Thismight be because
some of the serum samples were obtained during the acute phase
of illness; therefore, the immune response elicited was not enough
to be detected usingMAT.We also found that some PCR-negative
samples were diagnosed as positive by MAT. Although we do not
have evidence for this, we think it might be caused by Leptospira,
which is not always excreted in the urine of leptospirosis patients,
or that the number of Leptospira in the urine was below the detec-
tion limit of PCR. Another possible cause of this discrepancy is
that antibiotics used by the patients eradicated Leptospira in the
TABLE 5 Comparison of ICG-based LFA results with PCR (human
urine) and/or MAT (human serum)a
ICG-based LFA
PCR and/or MAT
Positive Negative Total
Positive 31 3 34
Negative 4 20 24
Total 35 23 58
a Sensitivity, 0.89 (89%) (95% CI, 0.78–0.96); specificity, 0.87 (87%) (95% CI, 0.8–
0.96). Values are number of samples.
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kidneys, making it undetectable by PCR. Recently, it has been
hypothesized that MAT is an imperfect gold standard for lepto-
spirosis (43). Therefore, a combination of PCR and MAT as the
gold standardmightmore precisely predict the true sensitivity and
specificity of the diagnostic assays that we developed.
The results in Table 3 show that both of our assays could detect
the leptospiral antigen in urine from the first day after the onset of
illness. However, until the fifth day after onset, some results of the
dipstick assay and ICG-based LFA were different from those with
the gold standard. This might be because during that time, the
antigen or intact bacteria that are excreted in urine are still low in
number or are excreted intermittently. Saengjaruk et al. (9) also
showed varied results of antigen detection in urine samples col-
lected consecutively, which is caused by the intermittent shedding
of Leptospira in urine. Results for urine samples from infected
patients, tested after the sixth day postonset, showed relatively
consistent results with those of the gold standard, which might be
caused by an increasing number and continuous shedding of Lep-
tospira or its antigen. Prolonged shedding of leptospires in the
urine (collected at the 52nd and 68th days after onset of illness)
was also found in two patients who tested positive in the two
assays. For the urine samples from healthy persons, the dipstick
assay showed two false positives, while ICG-based LFA showed
results consistent with those of the gold standard.
The sensitivity and specificity of the dipstick assay used for
human urine samples were 80% and 74%, respectively, higher
than those (76% and 65%, respectively) for the hamster urine
samples. Although we do not have evidence yet, we think that this
is because the concentration of Leptospira antigen in hamster
urinewasmostly below the detection limit andwas lower than that
in human urine. However, the sensitivity and specificity of the
dipstick assay for human urine were lower than those of the ICG-
based LFA, which were 89% and 87%, respectively. This might be
caused by the treatments of the sample pad and the conjugate pad.
The presence of dextran and the nonionic detergent Tween 20 at
low concentrations in the sample padmight enhance resolubiliza-
tion of the conjugate, reduce nonspecific reactions, and minimize
adsorption of the analyte on membrane (26). The addition of
sucrose, which is known as a preservative and resolubilization
agent (26), to the conjugate pad made the gold conjugate more
stable and flow better. Even though the overall sensitivity and
specificity of the ICG-based LFA are still 90%, they are still
higher than those of the IgMdipstick assay (9), which is often used
in an initial screening for leptospirosis. In summary, we have de-
veloped assays that can detect the presence of Leptospira antigen in
the urine of humans and animals and can discriminate it from
other bacterial antigens; however, this assay is not able to identify
the infecting serovar of Leptospira. We have also developed new
approaches for eliminating nonspecific reactions and concentrat-
ing urine. This is the first study that could detect Leptospira
antigen in human and hamster urine by the use of immunochro-
matography-based assays with good sensitivity and specificity.
Further development is needed in the pretreatment of samples
and applications for mass production in order to be applicable to
resource-poor areas, where leptospirosis is usually endemic.
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